HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+23.75%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(-86%)
Cap. Flow
-$719M
Cap. Flow
% of AUM
-658.8%
Top 10 Holdings %
Top 10 Hldgs %
91.26%
Holding
65
New
6
Increased
2
Reduced
11
Closed
43
Top Buys
| 1 |
DexCom
DXCM
|
$7.69M |
| 2 |
Acrivon Therapeutics
ACRV
|
$3.27M |
| 3 |
CONMED
CNMD
|
$2.44M |
| 4 |
Intuitive Surgical
ISRG
|
$1.53M |
| 5 |
Penumbra
PEN
|
$1.11M |
Top Sells
| 1 |
AbbVie
ABBV
|
$41.6M |
| 2 |
Agilent Technologies
A
|
$41.1M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$40.5M |
| 4 |
Boston Scientific
BSX
|
$37.1M |
| 5 |
Eli Lilly
LLY
|
$33.4M |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BioMarin Pharmaceuticals
BMRN
$11.2B
| $38.1M | 34.88% | 367,765 -391,273 | -52% | -$40.5M |
|
|
2
DexCom
DXCM
$29.5B
| $36.4M | 33.35% | 321,380 +67,880 | +27% | +$7.69M |
|
3
Cytokinetics
CYTK
$4.23B
| $7.53M | 6.91% | 164,440 -270,120 | -62% | -$12.4M |
|
|
4
Acrivon Therapeutics
ACRV
$42.2M
| $3.27M | 3% | +284,201 | New | +$3.27M |
|
5
Hyperfine
HYPR
$97.4M
| $3.26M | 2.99% | 3,880,900 +1,131,500 | +41% | +$950K |
|
6
Alkermes
ALKS
$4.78B
| $2.87M | 2.63% | 110,000 -193,500 | -64% | -$5.06M |
|
|
7
CONMED
CNMD
$1.68B
| $2.44M | 2.23% | +27,500 | New | +$2.44M |
|
8
Neurocrine Biosciences
NBIX
$13.8B
| $2.39M | 2.19% | 20,000 -1,720 | -8% | -$205K |
|
9
Syndax Pharmaceuticals
SNDX
$1.41B
| $1.78M | 1.63% | 70,000 -789,240 | -92% | -$20.1M |
|
|
KDNY
10
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.57M | 1.44% | 60,000 -206,830 | -78% | -$5.42M |
|
|
11
Intuitive Surgical
ISRG
$170B
| $1.53M | 1.4% | +5,750 | New | +$1.53M |
|
|
BPMC
12
DELISTED
Blueprint Medicines
BPMC
| $1.31M | 1.2% | 30,000 -74,600 | -71% | -$3.27M |
|
13
Geron
GERN
$893M
| $1.21M | 1.11% | 500,000 -1,404,234 | -74% | -$3.4M |
|
|
14
Penumbra
PEN
$10.6B
| $1.11M | 1.02% | +5,000 | New | +$1.11M |
|
15
Rocket Pharmaceuticals
RCKT
$354M
| $979K | 0.9% | 50,000 -395,140 | -89% | -$7.73M |
|
|
RAIN
16
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $960K | 0.88% | +120,000 | New | +$960K |
|
17
Inspire Medical Systems
INSP
$2.77B
| $882K | 0.81% | 3,500 -34,740 | -91% | -$8.75M |
|
|
SILK
18
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $793K | 0.73% | +15,000 | New | +$793K |
|
|
IMGN
19
DELISTED
Immunogen Inc
IMGN
| $744K | 0.68% | 150,000 -1,150,000 | -88% | -$5.7M |
|
|
EQRXW
20
DELISTED
EQRx, Inc. Warrant
EQRXW
| $9.45K | 0.01% | 35,239 | – | – |
|
|
EUCRW
21
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
| $4.34K | ﹤0.01% | 78,059 | – | – |
|
|
MSACW
22
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
| $2.68K | ﹤0.01% | 29,776 | – | – |
|
|
23
Agilent Technologies
A
$35.7B
| – | – | -338,030 | Closed | -$41.1M |
|
|
24
AbbVie
ABBV
$372B
| – | – | -310,250 | Closed | -$41.6M |
|
25
Abbott
ABT
$231B
| – | – | -98,970 | Closed | -$9.58M |
|